Median debuts lesion management applications
Median Technologies of Biot, France, introduced its complete portfolio of lesion management solutions, highlighted by its LMS-Lung/Track and LMS Liver applications, at the 2007 Radiological Society of North America (RSNA) annual conference last month.
The applications segment user-identified lesions and measure their key characteristics such as volume and longest axial diameters. They also automatically pair the lesions in follow-up exams, compute their growth and doubling time and then generate reports according to the response evaluation criteria in solid tumors (RECIST) used in oncology, Median said.
LMS-Lung/Track and LMS-Liver support chest or liver images acquired on any multi-slice CT scanner, and can be integrated with modality or PACS/RIS workstations. The company said its development efforts have resulted in delivering the applications to clinicians’ desktops instead of having them move to dedicated workstations.
Integrating advanced clinical applications with PACS or RIS workstations is key in diagnostic oncology imaging, Median said. It guarantees access to the patients’ previous exams necessary to perform follow-up studies, and allows for an immediate report transmission to oncologists.
Median Technologies is currently deploying its LMS applications in 15 countries across Europe and expects to do the same in the United States in the coming months, with the recent extension of its North American sales force, the company said.
The applications segment user-identified lesions and measure their key characteristics such as volume and longest axial diameters. They also automatically pair the lesions in follow-up exams, compute their growth and doubling time and then generate reports according to the response evaluation criteria in solid tumors (RECIST) used in oncology, Median said.
LMS-Lung/Track and LMS-Liver support chest or liver images acquired on any multi-slice CT scanner, and can be integrated with modality or PACS/RIS workstations. The company said its development efforts have resulted in delivering the applications to clinicians’ desktops instead of having them move to dedicated workstations.
Integrating advanced clinical applications with PACS or RIS workstations is key in diagnostic oncology imaging, Median said. It guarantees access to the patients’ previous exams necessary to perform follow-up studies, and allows for an immediate report transmission to oncologists.
Median Technologies is currently deploying its LMS applications in 15 countries across Europe and expects to do the same in the United States in the coming months, with the recent extension of its North American sales force, the company said.